Influence of the Epstein-Barr Virus Nuclear Antigen EBNA 2 on the Growth Phenotype of Virus-transformed B Cells
Overview
Authors
Affiliations
Epstein-Barr virus (EBV) isolates show sequence divergence in the BamHI YH region of the genome which encodes the nuclear antigen EBNA 2, a protein thought to be involved in the initiation of virus-induced B-cell transformation; type A isolates (such as B95-8 EBV) encode a 82- to 87-kilodalton EBNA 2A protein, whereas type B isolates (such as AG876 EBV) encode an antigenically distinct 75-kilodalton EBNA 2B protein. In the present work 12 type A isolates and 8 type B isolates have been compared for their ability to transform resting human B cells in vitro into permanent lymphoblastoid cell lines. Although the kinetics of initial focus formation was not markedly dependent upon the EBNA 2 type of the transforming virus, on subsequent passage type A virus-transformed cells (type A transformants) yielded cell lines much more readily than did type B transformants. Direct comparison between the two types of transformant revealed clear differences in several aspects of growth phenotype. Compared with type A transformants, cell lines established with type B virus isolates consistently displayed an unusual growth pattern with poor survival of individual cells shed from lymphoblastoid clumps, a lower growth rate and a greater sensitivity to seeding at limiting dilutions, and a significantly lower saturation density that could not be corrected by supplementation of the medium with culture supernatant containing B-cell growth factors. This is the first direct evidence that, in EBV-transformed B-cell lines, the EBNA 2 protein plays a continuing role in determining the cellular growth phenotype.
Research landmarks on the 60th anniversary of Epstein-Barr virus.
Zhong L, Xie C, Zhang L, Yang Y, Liu Y, Zhao G Sci China Life Sci. 2024; 68(2):354-380.
PMID: 39505801 DOI: 10.1007/s11427-024-2766-0.
Lurain K, Ramaswami R, Krug L, Whitby D, Ziegelbauer J, Wang H Clin Microbiol Rev. 2024; 37(3):e0002223.
PMID: 38899877 PMC: 11391709. DOI: 10.1128/cmr.00022-23.
Habibollah M, Azarakhsh A, Shahab M, Somayeh S, Shahram B, Ali R Arch Razi Inst. 2024; 78(5):1495-1502.
PMID: 38590671 PMC: 10998940. DOI: 10.22092/ARI.2023.78.5.1495.
Distribution of Epstein-Barr virus in the oral cavity of Thais with various oral mucosal conditions.
Vorakulpipat P, Kitkumthorn N, Lapthanasupkul P, Rungraungrayabkul D, Klongnoi B, Khovidhunkit S Heliyon. 2024; 10(2):e24222.
PMID: 38293426 PMC: 10826676. DOI: 10.1016/j.heliyon.2024.e24222.
The Impact of Co-Infections for Human Gammaherpesvirus Infection and Associated Pathologies.
Chinna P, Bratl K, Lambarey H, Blumenthal M, Schafer G Int J Mol Sci. 2023; 24(17).
PMID: 37685871 PMC: 10487760. DOI: 10.3390/ijms241713066.